Pulmonary Edema With Heart Failure

2

Review clinical trials related to Pulmonary Edema With Heart Failure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

MRI Assessment of Pulmonary Edema in Acute Heart Failure

Researchers are testing a more accurate way to measure how much fluid is in the lungs (also called pulmonary edema, or "increased lung water") in people with Heart Failure (HF) using MRI (Magnetic Resonance Imaging). There is little known about the exact level of lung water in patients with AHF or how these levels change from the time of hospital admission to discharge. The purpose of this research study is to measure the lung water in patients hospitalized for HF, to determine the change in lung water over the course of hospitalization and treatment, and to find out if lung water levels can predict if patients are higher or lower risk for returning to the hospital or dying from heart failure.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of AlbertaUpdated: May 8, 2026Locations: 2
Eligibility criteria

18 years of age or older and willing/able to provide informed consent [+3]

contraindication to MRI [+2]

Status: Recruiting

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients

Prospective, single-center, clinical registry of patients with symptomatic/critical carotid artery stenosis at risk of stroke coexisting with unstable or multivessel severe coronary artery disease and/or severe valvular heart disease undergoing endovascular treatment of carotid atherosclerosis using a mesh stent in combination with cardiac surgery (coronary artery bypass grafting (CABG) and/or valve surgery). A study involving clinical data evaluation of truly simultaneous treatment outcomes in patients deemed to require carotid revascularization at the time of surgical cardiac intervention (single-stage, simultaneous treatment). An open-label study, without randomization - a single arm study. Academic Registry - scientific activity of the Faculty of Medicine, Collegium Medicum, Jagiellonian University and John Paul II Hospital.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: John Paul II Hospital, KrakowUpdated: Jul 22, 2021Locations: 1
Eligibility criteria

Patients eligible for concomitant carotid artery stenting in conjunction with ca... [+7]

Expected survival time <1 year (e.g., cancer). [+12]